Mobia Medical Announces Pricing of Initial Public Offering
Mobia Medical
May 8, 2026
Apotex has acquired Cumberland Pharmaceuticals, a pharmacy business in Tennessee, for an undisclosed amount. Cumberland Pharmaceuticals operated in the pharmacy sector, supplying pharmaceutical products and related commercial activities that fit Apotex acquisitions and broader healthcare M&A goals. Apotex acquisitions support a strategic acquisition strategy to expand pharmacy offerings and strengthen distribution and regulatory capabilities in TN acquisitions. The divestiture acquisition is an announced strategic acquisition by a strategic buyer, with deal terms governed through an asset purchase agreement and regulatory commitments, including intellectual property and government price reporting obligations.
Mobia Medical
May 8, 2026
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026